Parenteral Flashcards

1
Q

What does parenteral mean?

A
par(a) = beside/outside
enetral = intestine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is parenteral administration?

A
  • par(a) = beside
  • enteral = intestine
  • therefore any route that bypasses the intestine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the BP definition of parenteral administration?

A

sterile preparations for administration by injection, implantation, infusion into humans or animals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

According to the BP, parenteral preparations must be sterile. What are two approaches to sterilisation and what do they need to ensure and avoid?

A
  • aseptic preparation
  • terminal sterilisation
  • need to ensure sterility
  • need to avoid contaminants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why is parenteral administration useful? (5)

A
  • can be used for drugs w low stability in GIT
  • local administration - higher concs e.g. intra-ocular
  • GIT may not be available
  • rapid onset of action; emergencies (no additional step like with caps and tabs)
  • achieving prolonged release (implants, IM)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What types of drugs is parenteral administration useful for? (2)

A
  • those with low stability in the GI tract

- those which need prolonged release (implants, IM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In what patient-related situations is parenteral administration useful?

A
  • emergencies: due to rapid onset of action

- unconscious/dysphagia: makes GIT unavailable as patient cannot swallow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the 3 main routes of parenteral administration?

A
  • intravenous (25 degrees)
  • subcutaneous (45 degrees)
  • intramuscular (90 degrees, deepest needle)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

whats IV route of parenteral admin: administered into and used for?

A

veins inside dermin

used for allergy tests etc…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

where is IM injected into?

A

deepest of the injections
90 degree angle

tissue layer under dermis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Apart from the 3 main routes, what are other routes of parenteral administration?

A
  • intra-arterial
  • intra-articular (joints)
  • intra-synovial
  • intracameral
  • intracardiac
    ….
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

describe IV injection- how much and where admin?

A

Single dose
Continuous infusion: therefore control rate
Peripheral or central vein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

IV volume administered- when is small vol used and when large?

A

Small (<10 mL)
Emergency

Large (>500 mL)
Fluid replacement
Nutrition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

types of IV formulation examples

A

Aqueous:

  • Solutions
  • Emulsions
  • Nanosuspensions not normal as bigger particles can embolise in small capillaries
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

routes of Intravenous administration? (2)

A

Peripheral vein
• Forearm/elbow
• Back of hand

Central vein
• Frequent access required
• Limited peripheral access

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

examples of intravenous administration

A
  • Antibiotics (long term)
  • Parenteral nutrition
  • Chemotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

IV soln may be irritating. how can you avoid damaging peripheral veins?

A

can dilute, prevent pain and irritation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

advantages of IV administration

A
  • 100% bioav
  • rapid onset of action
  • rapid dilution in blood circ
  • useful if drug too irritating for SC/IM
  • self admin possible- e.g. PCA devices
  • useful is no other routes available
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

disadvantages of parenteral administration (all)

A
  • Invasive, inconvenient, restrictive
  • Training required
  • Strict sterility requirements
  • Higher production costs
  • Aseptic techniques required
  • Risk for conversion errors
  • Can be/is perceived as painful
  • Management of waste (sharps)
  • Formulation can be challenging
  • Difficulty to self-administer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Subcutaneous administration: injection- where?

A

Fatty tissue under dermis
Upper arm
Anterior thigh
Lower abdomen

Proximity of capillaries
tissues-> caps -> blood circ -> lymphatic circs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Subcutaneous administration: volume- how much and mixed with what?

A
Small (1-2 mL)
Large with:
	Divided doses
	Hypodermoclysis
		SC infusion
			Slow rate
			Palliative/hydration
To be mixed with hyaluronidase: break down connective tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Subcutaneous administration types of formulation?

A

Aqueous solutions
Aqueous suspension
Oily solutions
Oily suspensions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Subcutaneous administration formulation and liposolubility impact on? (2)

A

Diffusion rate

Onset of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

use of hyaluronidase in SC preps?

benefit

A

Hyalase
mix w drug, : break down connective tissue
allow admin of larger volumes?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

2 examples of large volume SC?

A

Trastuzumab (Herceptin®)
- 5 mL over 2-5 minutes

Rituximab (MabThera® SC)
- 11.7 mL over 5 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

SC 3 advantages?

A

Considered more patient friendly than IV
Patients can be taught to self inject
Formulations can be made as suspensions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

specific SC disadvantages?

A

same as all parenterals PLUS:

  • <100% bioavailability
  • Response not always predictable
  • Some enzymatic activity (e.g. peptidases)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

whys response not always predictable in SC admin? what 3 factors influence it?

A

Impact of changes in :
• Blood supply
• Temperature
• Site of injection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

2 disadvantages specific to IM?

A

same as all parenterals PLUS:

  • Risk of embolism !!!
  • Risk of extravasation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

IM injection- where administered?

A

Skeletal muscle - Below SC tissue
Far from
• nerves
• blood vessels

Upper arm - Deltoid
Thigh - Vastus lateralis
Buttock - Gluteal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Intramuscular administration what vols administered and where?

A

Small (< 4 mL)

Up to 10 mL in divided doses
• Gluteus in adults
• Thigh in younger patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

types of IM formulation?

A
  • Aqueous solutions
  • Aqueous suspension
  • Oily solutions
  • Oily suspensions
  • Oily emulsions

Impact of formulation and liposolubility on
• Diffusion rate
• Onset of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

4 examples of IM administation?

A

COVID-19 (and other) vaccines
Haloperidol decanoate
Penicillin G benzathine
EpiPen®

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

IM advantages?

A
Considered more patient friendly than IV 
Rapid onset of action possible 
Variety of formulations available 
Alternative to SC for irritant drugs 
Useful if no other routes possible
Possible controlled release 
Better than SC for larger volumes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

IM specific disadvantages? (2)

A

Difficulty to self-administer

Impact of blood supply on absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

what else to consider specifically with IM admin?

A

With muscle: think about exercise and affect on blood supply

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

5 categories to consider in formulations?

A
sterility- avoids natural mech of defense+ phys barriers
excipients
containers
endotoxins: bacterial byproduct
particulates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

what must excipients be like in these formulations?

A

Can play different roles but must be compatible and nontoxic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

what must containers be like in these formulations?

A

Can be made of glass or plastic, ideally clear
Should protect the product from contamination during storage
Should be tamper-evident so can see if anyhting gone out/in

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

what to consider regarding endotoxins in these formulations?

A

Lipopolysaccharides (LPS)
Endotoxins cause fever and can cause shock. must control levels carefully
See Sterile products for depyrogenation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

what to consider regarding particulates in these formulations?

A

Free of visible particles

Limited sub-visible particle content

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

what will the BP provide information on?

A
  • Limits for sub-visible particles

* Limits for bacterial endotoxin units (pyrogens)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

in BP, what will Limits for sub-visible particles depend on? and 2 exemptions?

A

route of administration: IV stricter limits than other two
Usually higher for SC or IM

Exemptions:
o Radiopharmaceuticals
o Products to be used with a final filter (final product must meet requirement)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

in BP, what will Limits for bacterial endotoxin units (pyrogens) depend on?

A

route of administration and maximum dose recommended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

what 6 features of excipients to consider?

A
  • Isotonicity
  • pH
  • Solubility
  • Drug stability
  • Formulation shelf-life
  • Preservation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Parenteral formulations: 3 types of form?

A

solutions
emulsions
suspensions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Parenteral formulations: solutions used what do they req? (4)

A
Water for injections
Co-solvents
	Ethanol
	Glycerol
	Propylene glycol
Solubilising agents
	Surfactants
	Cyclodextrins
Suitable oil
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Parenteral formulations: emulsion used what do they req? (3)

A
w/o or o/w. contain:
Water for injections
Emulsifiers
	Lecithin
	Sorbitan fatty acid ester
Suitable oils
	Arachis oil
	Sesame oil
	Soybean oil
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Parenteral formulations: suspensions used what do they req?

A

can be aqueous or oily too

  • Water for injection
  • Suspending agents
  • Wetting agents. Surfactants e.g polysorbate
  • Suitable oils
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

role of suspending agents in emulsions and example?

A

Increase viscosity and stability and change drug release profile

Methylcellulose (IM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

what are suspensions best for?

A

best for SC and IM.
risk of embolism with IV.
but if have colloidal susp for nanomedicines, can administer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

what other excipients may be added to parenteral prep?

A

preservatives

  • Multi-dose injections: not using whole contents of vial in one go. Must maintain stability
  • Generally low concs
  • Co-solvents: have some issues but higher concs

antioxidant

buffers: acidifying/alkalinising agents for pH control

Tonicity adjustment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

examples of preservatives and concs used in paenteral?

A
Benzalkonium chloride 0.01
Benzoid acid 0.17
Benzyl alcohol 1-2
Chlorobutanol 0.1-0.5
Chlorocresol 0.1
Cresol 0.15-0.3
Ethanol >10 % v/v
Glycerol 10-20 % v/v
Propylene glycol 15-30 % v/v
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

examples Antioxidants excipients used in parenteral administration

A
  • Nitrogen gas Oxygen displacement Used to fill the headspace
  • Ascorbic acid (vitamin C) 0.01-0.1
  • Alpha-Tocopherol (vitamin E) 0.001-0.05
  • Butylated hydroxyanisole (BHA) 0.03 (IM)
  • Butylated hydroxytoluene (BHT) 0.0002-0.002 (IV)
  • Sodium metabisulphite (acid) 0.01-0.1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

what antioxidant excipient is also used as pH adjustment?

A

Ascorbic acid (vitamin C) 0.01-0.1%w/v

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Antioxidant activity potentiated by what agents? 2 examples

A

chelating agents
• Citric acid 0.3-2.0%
• EDTA 0.0005-0.01 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

how is pH controlled and in what range?

A

Ideal pH ca. 7.4

Acceptable range: 3.0-9.0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

2 examples of Acidifying agents?

A

HCl

Sulfuric acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

3 examples of Alkalinising agents?

A

Sodium bicarbonate
Sodium citrate
Sodium hydroxide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

what may cause pH changes?

A
  • Interaction with container

* Changes in storage conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

6 examples of buffers used (excipients)?

A
  • Citric acid
  • Sodium citrate
  • Sodium acetate
  • Sodium lactate
  • Monobasic sodium phosphate
  • Dibasic sodium phosphate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

tonicity reminder, define:
• Isotonic
• Hypotonic
• Hypertonic

A
  • Isotonic (osmotic pressure = plasma)
  • Hypotonic (osmotic pressure < plasma)
  • Hypertonic (osmotic pressure > plasma)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

what 2 excipients may be used to adjust tonicity?

A
  • Sodium chloride

* Dextrose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

what is Blood osmolality value range?

A

Blood osmolality 280-295 mmol/kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

antioxidants: how is N gas used?

A

N gas bubbled into preparation to replace oxygen and lower risk of oxidation OR if have vial/ampoule, use N gas to fill headspace, limit oxidation as preparation in low O2 environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

antioxidants: which one used for aq preps and which for oily preps?
why are they good

A
  • For aqueous: ascorbic acid/ Vitamin C
  • For oily: Vitamin E.

Good, work at low temps.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

3 Categories of parenteral preparations

A

Injections and infusions
o Concentrates for injections or infusions
o Powders for injections or infusions

Gels for injections

Implants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

Injections and infusions- why useful?

and types?

A

Ready to inject or infuse- no preparation req

single dose (pre-filled syringes, ampoules) or multi-dose (vials) containers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

what are infusions?

A

Aqueous solutions/ emulsions. Intravenous usually- follow same restrictions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

restrictions/ rules of infusions?

A
  • Isotonic to blood
  • Large volume parenterals (LVP): 100-1000mL, No antimicrobial preservatives
  • Sterile solutions: Clear and free of particulates
  • Sterile emulsions: Aqueous emulsions, No phase separation (cracking/creaming)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

in infusions, antimicrobial preservatives should NOT be used when?

A
if:
Single dose is > 15 mL
Route of administration is:
• Intracisternal (in subarachnoid cisternae- CSF of brain ventricules)
• Epidural
• Intrathecal
• ...to the CSF
• Intra-ocular
• Retro-ocular
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

what are pharm. Injections ?

A

Sterile solutions: clear and almost fully particle free. (esp for IV- risk of embolism, avoid)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

4 examples of pharm injections?

A
  • Insulin solution
  • Fluid replacement
  • Antibiotics (e.g metronidazole)
  • Blood-related products
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

injections & infusions are…

A

Sterile emulsions:
• No phase separation: cracking/ creaming- reversible but avoid
• < 3 microM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

injections & infusions 3 examples and uses

A

• Diazemuls®- diazepam in o/w emulsion
Sedation. Premedication for general anaesthesia
Muscle spasms/convulsions
Control of anxiety/agitation in delirium tremens

• Propofol (Diprivan®)
General anaesthesia

• Parenteral/total parenteral nutrition
Essential fatty acids
Used in drug formulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

sterile suspensions- 3 facts

(compaction, RoA, which is preferred RoA)?

A
  • No caking- compact sediment, hard to go back into suspension
  • SC or IM (coarse suspensions)
  • IV possible (colloidal suspensions)100nm approx.. small particles, avoid embolism risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

hows Powder for injection/suspension given/ used?

A
  • To be reconstituted
  • Suitable vehicle- Vehicle for reconstitution must be compatible- avoid accidental caking.
  • Importance of particle size
78
Q

what do injection or infusions require?

A

additional handling prior to administration

• Powder for injection
Sterile solids forming a solution or suspension after reconstitution
Usually lyophilised- need to add a suitable sterile vehicle

• Powder for concentrate for solution for injection/infusion
Need to add a suitable vehicle, then need to dilute prior to administration

• Concentrate for solution for injection/infusion
Need to dilute prior to administration

79
Q

injection or infusion recon … what to follow?

A
  • Instructions provided on how to reconstitute and/or dilute- must follow carefully
  • Final product must meet requirements for injections/infusions
80
Q

Gels for injections
i.e. viscous solutions

can be?(2)

A

-Sterile semi-solid preparation

-Modified release 
Somatuline Autogel®
Acromegaly
Gastroenteropancreatic neuroendocrine tumours
Neuroendocrine tumours
81
Q

how are Gels for injections administered?

what can patients be trained on?

A

Deep SC (no fold of skin prior to injection)prefilled syringe. Patients can be trained on how to self inject

82
Q
  1. implants RoA?
A

SC or IM usually

83
Q

implants types + what dot hey consist of?

A

Pellets/Rods
Sterile
Drug +/- excipients- depends on properties
Biodegradable or not think about how to remove- surgical process

84
Q

of rod implant?

A

ZoladexTM implant- biodegradable
• Goserelin
LHRH analogue (nonapeptide)
Prevents testosterone/oestrogen production
Hormone sensitive prostate/breast cancers
Endometriosis/endometrial thinning
Uterine fibroids
Assisted reproduction: preparation for superovulation
• Biodegradable polymer matrix
• Rod 1.5 x 18 mm q28 days

85
Q

example of rod implant?

A

ZoladexTM implant- biodegradable
• Goserelin
LHRH analogue (nonapeptide)
Prevents testosterone/oestrogen production
Hormone sensitive prostate/breast cancers
Endometriosis/endometrial thinning
Uterine fibroids
Assisted reproduction: preparation for superovulation
• Biodegradable polymer matrix
• Rod 1.5 x 18 mm q28 days

86
Q

example of comtraceptive implant?

A
Nexplanon 
•	Contraceptive implant, non-biodegradable
•	Subdermal (radio-opaque)
•	Non-biodegradable polymer
•	Progestagen (etonogestrel) only
•	3 years then surg. removed
87
Q

example of ocular implant?

A
Oxurdex® 
•	Intravitreal (ocular)
•	Dexamethasone
•	Macular oedema/ inflammation (uveitis)
•	Administered by ophthalmologist
•	Slowly release drug over period of time
88
Q

example of implant for brain cancer?

A
GliadelTM wafer
•	Local delivery of carmustine
•	Glioblastoma- brain cancer. Anti cancer agent
•	Biodegradable polymer
•	Surgeon administered
89
Q

what are implants: resevoirs?

hows drug stored and released?

A
  • Drug encapsulated within metal/plastic or non-biodegradable polymer
  • Drug in solution/dispersed in co-polymer inside reservoir
  • Drug released by osmotic pressure
90
Q

how are resevoirs (implants) put in and taken out?

A
  • Special injection device or surgical installation

* Require removal (usually surgical)

91
Q

Parenteral preparation need to be sterile and what do they have limits on?

A

particulates and endotoxins

92
Q

main routes of parenteral admin?

A

IV, IM and SC
o Volumes site of injection and types of formulations will vary
o Advantages and disadvantages may vary depending on the route
o Only nanosuspensions injected intravenously (more in SoM 3)
o Oily preparations can only be injected SC or IM

Can help to prolong release and decrease the frequency of administration

93
Q

What type of prep used for parenteral admin?

A

Solutions, suspensions and emulsions

o Some of the formulation consideration will be similar to oral liquid dosage forms

94
Q

PK of parenterals

Pharmacokinetics involves what processes

A

A = absorption, D = distribution, M = metabolism, E = elimination

95
Q

What processes out of ADME give the information on the elimination of a drug?

A

metabolism + elimination

96
Q

With pharmacokinetics, we’re looking at the change in _ as a function of _

A

change in plasma concentration as a function of time

97
Q

ADME conc/time: can be ….

A

+ (appearance: absorption) drug leaves dosage form to get to site of action. Often blood circulation OR
- (disappearance: elimination also distribution) decline in conc. For degradation

98
Q

How can we write the change in plasma concentration/ time using d notation?

A

dC/dt

99
Q

What is the change in plasma concentration as a function of time equal to for a drug following zero-order kinetics?

A

dC/dt = k

100
Q

What is the change in plasma concentration as a function of time equal to for a drug following first-order kinetics?

A

dC/dt = kC

101
Q

What is the change in plasma concentration as a function of time equal to for a drug following second-order kinetics?

A

dC/dt = kC²

102
Q

typical plasma-concentration time graph. Include labels for: the axes, Cmax, tmax, MEC, MTC/MSC, the therapeutic window, the distribution phase, the absorption phase and on the y-axis the no effect, effect/potency, and toxic.

A

yellow diagram….

103
Q

What does MSC stand for?

A

maximum safe concentration

104
Q

What does MEC stand for?

A

minimum effective concentration

105
Q

During the distribution phase, where is the drug going?

A

drug is leaving the blood and entering the body tissues

106
Q

During the elimination phase, where is the drug going?

A

the drug is leaving the body

107
Q

What does the area under the plasma-concentration curve tell us? AUC

A

the total exposure of the drug

108
Q

What is the bioavailability of IV administration? Why?

A

100% - drug goes directly to the systemic circulation

109
Q

What is IV bolus administration?

A

a single intravenous injection

110
Q

why does IV admin not undergo first pass metab?

A

as direct to blood conc - no absorption phase

111
Q

What is known about IV bolus administration?

A

the initial dose C0

112
Q

IV bolus administration provides data only on…

A

the distribution and elimination of a drug

113
Q

How many compartments does IV bolus administration involve? so what does this mean

A

only one - the body (distribution is negigible)

114
Q

What phase is not present on a plasma-concentration curve for IV bolus administration that is present normally?

A

the absorption phase (straight to elimination)

just slope down

115
Q

What does the initial concentration of an IV bolus injection depend on?

A
  • the initial dose

- the volume of distribution of the drug

116
Q

Why does Vd affect the initial conc of an IV bolus injection? (hint: think of what concentration is normally)

A
  • conc normally mass/volume
  • Vd = amount of volume the drug will distribute itself to (includes plasma and fatty tissue)
  • therefore conc can be written as C = D/Vd
117
Q

What are the units for volume of distribution (Vd)?

A

Litres

118
Q

What types of properties of the drug can influence its volume of distribution? Why?

A

the physico-chemical properties:

  • lipophilicity
  • plasma protein-binding

these both affect how easy it is for the drug to leave the blood circ + DISTRIBUTE to other tissues

119
Q

What can Vd be used to estimate?

A

the plasma concentration/loading dose needed

120
Q

If the volume of distribution for a given drug is LARGE, what pharmacokinetic process (A/D/M/E) is important and why?

A
  • distribution

- there’s a high extravascular concentration as drug has left to go elsewhere in body

121
Q

With a high volume of distribution, how are the plasma concentration and half-life affected?

A
  • plasma concentration is decreased
  • half-life is increased

↑ Vd = ↑ t1/2

122
Q

Why (how) does volume of distribution affect half-life?

A

if the drug has left the blood (systemic circ), will take longer for the concentration to halve (and complete elimination)

123
Q

For the average 60kg patient, what is their plasma volume?

A

3.0L

124
Q

What does a high drug plasma level say about the volume of distribution and why?

A
  • low Vd
    Smaller theoretical amount of plasma to achieve that high concentration
  • most of the drug has remained in blood rather than distributing to other tissues
125
Q

How do plasma proteins affect the volume of distribution of a drug? (increase or decrease and why)

A
  • decrease
  • by binding to drug, they preventing the drug from leaving the circulation and distributing to other tissues

Reason: 99% plasma protein (albumin) bound = restricts distribution

126
Q

How do plasma proteins affect the ability of a drug to have its physiological effect?

A
  • they decrease it
  • by binding to a drug, it cannot have its physiological effect
  • therefore only unbound drug can have its physiological effect
127
Q

For elimination kinetics, what order do most drugs follow?

A

first

128
Q

What symbol is used to represent the rate constant, k?

A

λ

129
Q

Concentration in the plasma= low , Vd =?

and give drug example

A

high Vd
(Large theoretical amount of plasma to achieve the low plasma concentration)

Chloroquine Vd = 9000L-purely theoretical (for a 60 Kg adult)
Highly lipophilic partitions into fat

130
Q

how does increased dose affect conc?

A

Conc = quantity(dose)/volume (Vd)

Increased C with increased dose

131
Q

What is the equation for an elimination plasma-concentration time curve (e version) for first-order elimination kinetics?

A

C = C0e⁻^(kt)

132
Q

What is the equation for an elimination plasma-concentration time curve (ln version) for first-order elimination kinetics?

A

lnC = lnC0 - kt

133
Q

What is the equation for an elimination plasma-concentration time curve (log version) for first-order elimination kinetics?

A

logC = logC0 - λt/2.303

134
Q

What type of scale can we use to plot the plasma concentration curve and why is it useful?

A
  • semi-log paper

- easier to read and plot as x-axis is on linear scale

135
Q

How do we convert from ln to log?

A

ln(x) = 2.303 log(x)

136
Q

inc clearance affect on elim and plasma conc?

what about half life?

A

= faster rate of elimination = faster decline in plasma concentration Cl proportional to kEl (elimexcretionsunchanged in urine Plus  metabolism (liver) Directly prop

inc clearance = shorter half-life. Inversely prop

137
Q

What is the definition of clearance?

A

the volume of blood of drug eliminated from the body per hour

138
Q

What are the units for clearance?

A

L/hr

139
Q

How does a faster clearance affect the rate of elimination and plasma concentration?

A

increases the rate of elimination and increases the rate of decline of plasma concentration

140
Q

How does a faster clearance affect the half-life?

A

decreases the half-life

141
Q

What relationship of proportionality does the clearance have to the elimination rate constant?

A

clearance ∝ k

directly proportional

142
Q

What relationship of proportionality does the clearance have with the half-life?

A

clearance ∝ 1/t1/2

inversely proportional

143
Q

What clearances make up the total clearance?

A

total clearance = hepatic clearance + renal clearance + other clearance (e.g. lungs, sweat, etc.)

Kcl = Kr + Km
(rate constant for exc) + (rate constant for metabolism)

144
Q

What is the formula for total clearance?

A

total clearance = k x Vd

145
Q

What is the formula for half-life involving the elimination rate constant?

A

t1/2 = ln2/k

146
Q

increaseing clearance affect on half life?

A

shorter.
indirectly proportional

Cl – 1/ t1/2

147
Q

what does Kel = for first order?

A

time ^-1

148
Q

Combine the equations for the half-life of elimination and the total clearance. What does it show about the relationship between the two?

A
  • inversely proportional
  • if total clearance increases, half-life decreases
  • if total clearance decreases, half-life increases

t1/2 = ln2 x Vd / Clt

149
Q

For a drug administered via IV bolus injection, the dose is 500mg, the Vd is 50L, the total clearance is 2L/hr and the MEC is 2mg/L. What is the initial plasma concentration?

A

C0 = D/Vd

= 500mg/ 50L

= 10mg/L

150
Q

For a drug administered via IV bolus injection, the dose is 500mg, the Vd is 50L, the total clearance is 2L/hr and the MEC is 2mg/L. What is the half-life?

A

t1/2 = ln2/ k

= ln 2 x Vd / ClT !!

ln2 x 50L / 2L/h

= 17.3h

151
Q

For a drug administered via IV bolus injection, the dose is 500mg, the Vd is 50L, the total clearance is 2L/hr and the MEC is 2mg/L. How many half-lives will it take for the drug to be eliminated from the body?

A

4-5, considered eliminated when 95-97% has left body

1 t1/2 = 50% C0
2 t1/2 = 25% C0
3 t1/2 = 12.5% C0

[4 t1/2 = 6.25% C0
5 t1/2 = 3.125% C0]
95-97%

152
Q

For a drug administered via IV bolus injection, the dose is 500mg, the Vd is 50L, the total clearance is 2L/hr and the MEC is 2mg/L. How long will it take for the plasma concentration to fall below the MEC?

A

40.2 hrs

check p132!!!

153
Q

What order does the elimination of multiple IV bolus injections follow?

A

first-order

154
Q

How many compartments form the compartment system of multiple IV bolus injections?

A

one compartment system

system (distribution phase is negligible) so curve mostly tells about elimination

155
Q

Draw the plasma concentration graph for a multiple IV bolus injection where the dose exceeds the MSC. Label the MSC, MEC and therapeutic window.

A

p134 first pic

156
Q

What is the desired level of drug plasma concentration we want to achieve with multiple IV bolus injections?

A

steady state (Css)

157
Q

Sketch the plasma concentration graph for multiple IV bolus injections as it approaches steady state. Label the steady state, and axes.

A

p134

158
Q

What can you do to keep the plasma concentration within the therapeutic window (with multiple)?

A
  • Change dose- lower

* Change dosing interval- when given and how often (dose distribution)

159
Q

What is the definition of the steady state of multiple IV bolus injections?

A

the concentration at which the drug entry is equal to the drug exit - equilibrium

160
Q

What is the equation for the steady state of multiple IV bolus injections?

A

Css = Dose / total clearance x dosing interval (τ)

• Css is the steady state average concentration

161
Q

What can we do to achieve steady state for drugs with a low dose (i.e. takes too long for drug to reach MEC)?

A

use a loading dose as it will achieve the steady state concentration immediately

162
Q

What is the equation for loading dose?

A

LD = Css x Vd

163
Q

what does Css = dose/ Clt x dosing interval t

take into account?

A

that drug may not be completely excreted before next/couple doses administered.

164
Q

why is larger therapeutic window good for Css?

A

first dose (when getting up to Css) will more liekly be within range

165
Q

reason to give LD?

A

get into therap range straight away, to get to Css

Get response and effective treatment quickly- for seizures etc or cardiac disease

166
Q

Vancomycin is administered IV and has a narrow therapeutic window. Otoxicity has been associated w serum drug levels of 80-100mg/L, but not seen when below 30mg/L. 90% of injected dose excreted via glomerular filtration, the Vd = 35L, the t1/2 = 6 hrs. For repeated administration, trough concentrations prior to next dose should be 5-10mg/L. Initial dose given is 1g. Calculate the total clearance.

A

ClT = Kel x Vd

t1/2 = ln2 X Vd / ClT

4.04L/hr

167
Q

Vancomycin is administered IV and has a narrow therapeutic window. Otoxicity has been associated w serum drug levels of 80-100mg/L, but not seen when below 30mg/L. 90% of injected dose excreted via glomerular filtration, the Vd = 35L, the t1/2 = 6 hrs. For repeated administration, trough concentrations prior to next dose should be 5-10mg/L. Initial dose given is 1g. How many hours after the 1st dose should the next dose be administered?

A

C0 = 1000/35

C = 5-10mg/L

k = ln2/t1/2

use lnC = lnC0 - kt

= 9.12hrs?

168
Q

• After multiple administrations, the plasma concentration ….

A

increases steadily

169
Q

what is Css?

A

After a while, we reach steady state, at which point the plasma concentration will remain constant

170
Q

loading dose is NOT always required, it depends on what?

A

drug/clinical indication and on the plasma concentration achieved at a normal dose

further adjustments to subsequent doses (i.e. change to the maintenance dose) may be required if a loading dose is used

171
Q

What is the difference between an IV bolus injection and infusion in terms of the rate of concentration increase?

A

for a continuous infusion, the rate of concentration increase is more gradual

172
Q

What is the main difference in the way IV bolus injections and infusions are administered?

A

infusions are administered continuously (constant rate),

elimination only begins once the infusion is stopped

173
Q

IV or IM: know rate of infusiom?

A

IV.

still both admin directly into circulation though

174
Q

Speed of conc increase depends on what for IV infusion?

A

infusion rate.
Fast= sharp increase
Peak= when infusion stops- nomore drug put in

175
Q

What order of kinetics do IV infusions follow?

A

first

176
Q

Sketch the concentration time graph for an IV continuous infusion. Label the steady state on the y-axis, and the wash-in, steady-state, and wash-out period on top of the graph.

A

pic of p 137

177
Q

Wash in stage: influenced by ?

A

rate of infusion and how long infusion lasts.

178
Q

describe the Css stage on the graph

A

plateau. infusion stopped, drug coming in and out is the same

179
Q

What issue is encountered in terms of dosage for both multiple IV bolus injections and continuous IV infusions? How is it resolved?

A
  • both take a while to reach steady-state concentration (wash in stage)
  • can use a loading dose in both instances or increase infusion rate briefly until Css reached then slow down rate
180
Q

What does the concentration time graph have for IM/SC injections that IV bolus injections/infusions don’t? Why?

A
  • an absorption phase

- the drug needs to leave the dosage form and enter the systemic circulation

181
Q

Put the following dosage forms in order of decreasing rate to onset of action: aqueous suspension, oil-based suspension, aqueous solution, oil-based solution.

A
  • aqueous solution
  • aqueous suspension
  • oil-based solution
  • oil-based suspension
182
Q

If want to change plasma conc, generally have to change (2)?

A

infusion rate OR duration of infusion

183
Q

plasma conc at steady state = Css. this is reached when t= ?

A

infinity

eqm drug in = out

184
Q

Clinical significance of t=t infinity. time takes to reach Css?

A

• Drug with long half-life: may take days to reach steady state
• Drug with short half-life: Css may be reached in hours
- Consider if loading dose useful. If takes long time to reach CSS: consider LD.

185
Q

similarity in continuous infusion and multiple bolus?

A

• Same build up, then reach steady state.

186
Q

Continuous or multiple bolus injectyions better to give in clinic?

A

Continuous…
else Dosing interval got wrong- dotted line have to wait until 3rd dose for MEC.
• Infusion- don’t have to wait with start and reaching effect.
• Loading dose possible
• Want to reach steady state conc ASAP

187
Q

options for clinical use: continuous/ multiple bolus injections?

A

LD: high conc initially but then reach desired conc asap. Different options on how to give:
• Give IV bolus injection then start with infusion. higher initial conc then over time reach Css.
• Or have infusion at higher infusion rate= in therapeutic window faster but then MUST readjust rate to stay in window for whole time. Must keep track of rate and slow down infusion once Css reached.
o May have issues with toxicity if not adjusted

188
Q

what to presc if need to get to Css quickly e.g. w antibiotics?

A

LD + infusion

equation w orange arrow !! p 139

Use this equation when calculating conc of drug in plasma at given time when have LD + IV bolus + infusion

Changing rate NOT = reach Css faster, BUT can get to higher levels.

189
Q

changing rate of infusion affect on Css time to get there?

A

Changing rate NOT = reach Css faster, BUT can get to higher levels.

Infusion rate changed at ONE HALF-LIFE
• Short half life: have less time to switch infusion rate. Long: have more time

190
Q

Why haloperidol not given IV? (Not oily- not IV anyway)

A

• Clinically: Haloperidol is not given iv for clinical reasons it can cause serious cardiac dysrhythmias if given iv.
• Formulation: look at the two formulations and at your lecture notes. Apart from the side effects mentioned, what else explains why IM
administration is preferred for haloperidol decanoate?